Metaverse in Healthcare Market
Immersive digital technologies, including augmented reality (AR) for surgical assistance and virtual reality (VR) therapy, are transforming the healthcare landscape. As per an analysis by DataM Intelligence, the global market for the metaverse in healthcare was estimated at around USD 11.35 billion in 2024. Projections indicate a dramatic increase to USD 287.4 billion by 2033, reflecting a compound annual growth rate (CAGR) of 43.2%.
Metaverse in Healthcare Market – Competitive Landscape
The competitive environment features a variety of key players, including Accuvein, Inc., Augmedics, Bioflightvr, Brainlab AG, CAE Inc., CMR Surgical, Eon Reality, GE Healthcare, Google, Immersivetouch, Inc., Intuitive Surgical, Inc., Koninklijke Philips N.V., Medtronic Plc, Merative, Microsoft, Mindmaze, Novarad Corporation, Nvidia Corporation, Oculus (Meta Platforms), Oodles Technologies, Siemens Healthineers AG, Wipro, Worldviz, Inc., XRhealth, and 8Chili, Inc.
Key developments in the sector include Mindmaze’s launch of NeuroXR in January 2025, aimed at cognitive rehabilitation through VR for patients with stroke and neurodegenerative conditions. In March 2025, Brainlab AG acquired Swiss startup VRmedTech to enhance its surgical navigation software with a VR-based anatomy engine tailored for neurosurgery and ENT fields. Additionally, CAE Inc. introduced CAE Mediverse in February 2025—a virtual reality simulation environment facilitating collaborative training among healthcare professionals across various locations. Novarad Corporation also announced the release of ARInsight in May 2025, an augmented reality tool that superimposes radiology data on patients during live procedures in select U.S. trauma centers.
Metaverse in Healthcare Market Segments
The market is segmented into several categories:
∎ By Component Type: Software, Hardware, Services
∎ By Technology Type: AR/VR, Mixed Reality, AI, Blockchain, Digital Twin, IoT, Medical Wearables
∎ By Application: Medical Training & Simulation, Telemedicine, Diagnostics, Digital Therapeutics, Clinical Research, Drug Discovery
∎ By End Users: Healthcare Providers, Pharma/Biopharma, Patients, Payers, Research Organizations
AR/VR dominates the technology segment, accounting for roughly 34% of the market, primarily due to its applications in surgical planning, diagnostic visualization, and rehabilitation.
Regional Insights & Adoption Trends
North America leads in the adoption of metaverse technologies, with over 35% of major hospitals in the U.S. employing AR/VR tools for surgical training, telehealth, and diagnostics by mid-2025. Strategic partnerships, such as those between Microsoft and Intuitive Surgical and the rollout of AI avatars by GE Healthcare, further solidify the region’s leadership in immersive healthcare technologies.
In the Asia-Pacific region, Japan is emerging as one of the fastest-growing markets, bolstered by collaborative initiatives between public and private sectors. In early 2025, Fujifilm and NVIDIA unveiled a digital twin operating suite in Japan designed for real-time surgical planning. Furthermore, government funding is propelling the adoption of AI and XR technologies in public hospitals through the national “Medical DX” initiative.
Recent Investments in U.S. & Japan
In the United States, noteworthy developments include the expansion of the virtual residency collaboration between Microsoft and Johns Hopkins University in April-May 2025, which integrates XR modules for anatomy training and surgical planning. In the first quarter of 2025, GE Healthcare launched AI avatar systems for virtual consultations across major hospital networks, reflecting the integration of metaverse solutions into routine medical care.
In Japan, the launch of a real-time digital twin operating suite by Fujifilm and NVIDIA in January 2025 enables immersive planning and guidance during surgeries. The Ministry of Health in Japan has also started allocating funds toward the implementation of AI-based XR modules in public hospitals as part of the national digital health modernization strategy.
Key Growth Drivers & Market Dynamics
Several factors contribute to the growth of the metaverse in healthcare. Mixed Reality (MR) systems, like HoloLens and Magic Leap, are facilitating 3D anatomical overlays and guided surgical procedures, with over 30% of leading U.S. hospitals utilizing MR for surgical navigation by mid-2025. XR technologies in training and diagnostics are revolutionizing medical education, with over 40% of top medical schools in North America and 30% in Japan expected to incorporate XR training into their curricula by 2025. AI-powered digital twins and blockchain platforms enhance precision diagnostics and data sharing across decentralized clinical networks. Additionally, regulatory measures are promoting the acceptance of virtual training hours for certifications and pilot deployments, driving institutional adoption.
Latest Developments in U.S. (2025)
In October 2024, CMR Surgical’s Versius robotic system gained FDA approval for gallbladder removal, utilizing mixed reality interfaces already applied in over 26,000 surgeries globally. In the first quarter of 2024, Medtronic filed 22 patents related to AR-enhanced surgical instruments, indicating ongoing investment in metaverse-compatible medical hardware.
Latest Developments in Japan (2025)
Japan’s healthcare landscape is also evolving, with the Fujifilm-NVIDIA digital twin operating suite launched in January 2025 for immersive surgical planning and intraoperative support. Moreover, public hospitals are receiving government funding to adopt AI and XR technologies for diagnostics and training, in line with the national Medical DX strategy aimed at accelerating the development of metaverse infrastructure.
Challenges & Future Opportunity
Despite the promising growth, challenges remain. Data privacy and cybersecurity concerns are significant, with nearly 48% of U.S. hospitals employing immersive technologies reporting security breaches. In Japan, compliance issues related to the Act on the Protection of Personal Information (APPI) pose barriers to implementation. High costs associated with hardware and software deployment also hinder adoption, particularly in resource-limited environments.
Conversely, opportunities abound in the transformation of medical education through XR simulations, which offer scalable and low-risk training options. Governments are increasingly recognizing these training hours for accreditation. Collaborations among technology giants and healthcare organizations, such as those between Microsoft and Intuitive Surgical or Fujifilm and NVIDIA, are leading to the establishment of robust virtual care networks. Furthermore, the application of immersive therapies utilizing VR for pain management, stress relief, and mental health treatment is on the rise.
Conclusion
DataM Intelligence’s analysis highlights that the metaverse in healthcare is one of the fastest-evolving sectors in digital health, expected to grow from USD 11.35 billion in 2024 to USD 287.4 billion by 2033, showcasing a CAGR of 43.2%. With significant adoption in North America and Asia-Pacific—driven by innovative collaborations in the U.S. and Japan—the healthcare metaverse is poised to transform clinical training, surgical practices, remote diagnostics, and patient therapies. Stakeholders who embrace secure, immersive, and integrated platforms will spearhead the shift towards a more intelligent, safer, and accessible healthcare system.
